Abstract
The ubiquitin specific protease 11 (USP11) is implicated in DNA repair, viral RNA replication, and TGFβ signaling. We report the first characterization of the USP11 domain architecture and its role in regulating the enzymatic activity. USP11 consists of an N-terminal “domain present in USPs” (DUSP) and “ubiquitin-like” (UBL) domain, together referred to as DU domains, and the catalytic domain harboring a second UBL domain. Crystal structures of the DU domains show a tandem arrangement with a shortened β-hairpin at the two-domain interface and altered surface characteristics compared to the homologues USP4 and USP15. A conserved VEVY motif is a signature feature at the two-domain interface that shapes a potential protein interaction site. Small angle X-ray scattering and gel filtration experiments are consistent with the USP11DU domains and full-length USP11 being monomeric. Unexpectedly, we reveal, through kinetic assays of a series of deletion mutants, that the catalytic activity of USP11 is not regulated through intramolecular autoinhibition or activation by the N-terminal DU or UBL domains. Moreover, ubiquitin chain cleavage assays with all eight linkages reveal a preference for Lys63-, Lys6-, Lys33-, and Lys11-linked chains over Lys27-, Lys29-, and Lys48-linked and linear chains consistent with USP11’s function in DNA repair pathways that is mediated by the protease domain. Our data support a model whereby USP11 domains outside the catalytic core domain serve as protein interaction or trafficking modules rather than a direct regulatory function of the proteolytic activity. This highlights the diversity of USPs in substrate recognition and regulation of ubiquitin deconjugation.
Ubiquitin specific proteases (USPs) contain a diverse range of ancillary domains,1−4 whose roles are poorly characterized for the majority of USPs. They are likely to hold the key to specificity in terms of targeting these proteases to protein complexes and cellular compartments, serve regulatory functions, and play a role in substrate selectivity such as in the most well studied member of the USP family USP7/HAUSP.5,6 The 105 kDa ubiquitin specific protease 11 (USP11) regulates vital signaling pathways in the nucleus. For example, USP11 acts as an upstream regulator of an IKKα-p53 signaling pathway7 and interacts with the NF-κB transcription factor RelB. The scaffolding protein RanBPM and the breast cancer type 2 susceptibility protein (BRCA2) have been identified as a substrate for deubiquitination and an interaction partner respectively,8,9 implicating USP11 in DNA damage repair. Indeed, USP11 exhibits pro-survival functions in the cellular response to DNA damage,9 and RNA interference studies revealed that repair of DNA double-strand breaks by homologous recombination is defective in USP11-silenced cells.10 A role of USP11 in transcriptional regulation by interacting with Polycomb complexes has also been identified,11 and viral proteins such as human papillomavirus HPV-16E7 and influenza A viral RNA replication complex proteins interact with and can be substrates for USP11 deubiquitination.12,13 Importantly, USP11 has been shown to exhibit altered expression levels in several types of cancers such as lung and breast cancer,14,15 and the enzymatic activity of USP11 is inhibited by mitoxantrone which affects pancreatic cancer cell survival.16 There is currently no structure for USP11 domains or information on how its catalytic activity is regulated and substrate is recognized.
USP11 is related by sequence to USP15 and USP4 referred to as the DUSP-UBL (DU) family of ubiquitin specific proteases that are predicted to share the same domain architecture harboring two internal ubiquitin-like (UBL) domains and an N-terminal domain present in ubiquitin-specific proteases (DUSP)17 as shown in Figure 1A. The cysteine protease domains contain an insertion with a nested UBL domain (UBL2), which was proposed to possess an autoinhibitory function in USP4,18 although the study supporting this has recently been retracted.19 On the basis of these data and the role of UBL domains in USP7, it has been proposed that USP11 may also be regulated through its two internal UBL domains.18 The N-terminal DUSP and UBL domains are more divergent than the catalytic core domains between USP4, USP11, and USP15 sequences and may additionally be involved in protein–protein interactions and targeting these proteases to different cellular compartments. In USP4 these domains mediate interactions with the spliceosomal recycling factor SART320 and the proteasomal subunit S9/Rpn6.21 In USP15 an interaction with the E3 ligase BRAP was reported.22 The crystal structures of the USP4 (Structural Genomics Consortium, unpublished) and USP15 N-terminal DU domains have been determined revealing a close association of the DUSP and UBL domains via a number of contacts and a β-hairpin DU finger structure.23,24 In the more distantly related USP11, the predicted DUSP domain shares a moderate 39% sequence identity with the DUSP domains of USP15 and USP4 and the adjacent UBL domain only 32% sequence identity. A low resolution molecular envelope of these domains appears more extended compared to USP4 and USP15,24 and it has been suggested that these domains adopt a different arrangement in USP11.24 We were therefore interested in elucidating the atomic resolution structure of the USP11 DU domains. Although a number of USPs show only moderate ubiquitin chain specificity,1 it is likely that both ubiquitin chain and target protein contribute to the overall specificity, and USPs may also aid in the recycling of these chains. It has been observed that USP11 can cleave isopeptide linked ubiquitin chains, but not linear diubiquitin.1 How the USP11 DUSP and two internal UBL domains that may act as ubiquitin mimics contribute to catalysis and whether they possess a regulatory function are currently unknown. Tight regulation of USP activity is vital for the control of signaling pathways and protein degradation,1,25 but research into USP regulation mechanisms is at an early stage. In this study we undertook the first examination of the domain structure of USP11 and determined crystal structures of the human (hUSP11) and rat (rUSP11) USP11 N-terminal DU domains, analyzed potential interaction surfaces, USP11’s oligomerization state and investigated the role of the ancillary domains in the catalytic activity and chain selectivity of USP11.
Experimental Procedures
Cloning, Expression and Purification
Full-length human USP11, residues 1–920 (FL-USP11), and a range of deletion mutants including 24–244 (hUSP11DU), 1–445/736–920 (FLΔUBL2), and 252–445/736–893 (CatΔUBL2) were amplified from I.M.A.G.E. clone 4180680. In the ΔUBL2 constructs a 290-residue deletion is substituted by a short linker, based on USP8 (PDB code 2GFO) residues 957–961 ASTSK, which connects residues 445 and 736. The N-terminal region from the rat USP11 gene encoding residues 19–236 (rUSP11DU) was amplified from I.M.A.G.E. clone 7190710. CatΔUBL2, hUSP11DU, and rUSP11DU were cloned into pET26b using NdeI and XhoI restriction sites. FL-USP11 and FLΔUBL2 were cloned into pCold1 using NdeI and HindIII restriction sites. The human ubiquitin sequence was inserted into pRSF-13 (Arie Geerlof, EMBL Hamburg, Germany) using NcoI and HindIII restriction sites. Protein expression was induced by adding 0.5 mM IPTG to BL21-CodonPlus cells grown at 37 °C in 2xYT medium to mid log phase. Cells harboring the hUSP11DU plasmid were harvested after 4 h. For rUSP11DU and CatΔUBL2 expression, cells were grown at 20 °C for 16 h before harvesting, and for FL-USP11 coexpressed with ubiquitin and FLΔUBL2 expression, cells were grown for 72 h at 10 °C prior to centrifugation. For rUSP11DU, hUSP11DU, and the CatΔUBL2 construct, cells were lysed by sonication in 20 or 50 mM Tris-Cl pH 7.5, 150 mM NaCl, 20 mM imidazole. Cells containing FL-USP11 and FLΔUBL2 were lysed in 50 mM Tris-Cl, 300 mM NaCl, 5% (v/v) glycerol, 20 mM imidazole. Samples were purified using HiTrap chelating columns (GE Healthcare) precharged with nickel sulfate. rUSP11DU, hUSP11DU, and CatΔUBL2 were further purified by size exclusion chromatography on a Superdex 75 16/60 column (GE Healthcare) pre-equilibrated with 50 mM Tris-Cl, pH 7.5, and 150 mM NaCl. FL-USP11 and FLΔUBL2 were further purified using a Superdex 200 16/60 column (GE Healthcare), pre-equilibrated with 50 mM Tris-Cl, pH 7.5, 300 mM NaCl, and 1% glycerol.
Crystallization
Crystallization trials of hUSP11DU and rUSP11DU were carried out using the hanging drop vapor diffusion method. The best diffracting crystals for hUSP11DU grew in Morpheus screen26 condition C4 containing 0.1 M MES/imidazole pH 6.5, 30 mM sodium nitrate, 30 mM sodium phosphate, and 30 mM sodium sulfate, 12.5% (w/v) PEG1000, 12.5% (w/v) PEG3350, 12.5% (v/v) MPD at a protein concentration of 10 mg mL–1. The crystals grew in less than 1 week and had a plate-like morphology. The best diffracting rUSP11DU crystals grew within 2 days at 7.5 mg mL–1 in a condition based on JCSG+ condition G8 containing 0.15 M malic acid pH 6.8, 24% (w/v) PEG3350, and 10 mM strontium chloride hexahydrate.
Data Collection, Structure Determination, and Refinement
Data from hUSP11DU crystals were collected on the microfocus beamline ID23-2 at the ESRF, France. Data were processed using iMosflm, and four data sets from the same crystal were scaled together using Aimless (CCP4 suite27). The structure was solved by molecular replacement in Phaser using the USP4 DUSP and UBL domains (PDB code 3JYU; SGC) as search models.28 The final model was generated through iterative rounds of model building in COOT and refinement using Phenix,29 with noncrystallographic symmetry restraints (NCS) and translation/libration/screw (TLS) groups from the TLSMD server used in the final rounds of refinement.30 The first nine residues and the His-tag of the hUSP11DU construct were not observed in the density and omitted from the final model. Nine surface residue side chains could not confidently be modeled and were truncated at the Cβ position; these comprise residues Gln95, Arg101, Asn203, Lys235, Lys236 from chain A and residues Glu187, Arg188, Asn203, Lys236 from chain B.
Data from a rUSP11DU crystal were collected at beamline ID29 at the ESRF, France. Data were processed using XDS31 and scaled using Aimless.27 The structure was solved by molecular replacement with Phaser using the DUSP and UBL domains from the hUSP11DU structure individually as search models. Restrained refinement using TLS groups was carried out in Refmac and Phenix27,29 using NCS restraints. The first seven and eight residues in chain A and B, respectively, were not clearly defined in the electron density and therefore not modeled. The side chain of Glu197 was truncated due to flexibility. The two copies in the asymmetric unit are linked by a nonphysiological disulfide bond formed between Cys204 in both copies. Data collection and refinement statistics are listed in Table 1. Atomic coordinates and structure factor files were deposited at a member site of the Protein Data Bank (www.rcsb.org) under accession codes 4MEL (hUSP11DU) and 4MEM (rUSP11DU).
Table 1. X-ray Data Collection and Refinement Statistics.
data set | hUSP11DU | rUSP11DU | ||
---|---|---|---|---|
space group | P21 | P22121 | ||
a, b, c (Å) | 27.7, 132.0, 72.0 | 37.3, 80.2, 149.3 | ||
α, β, γ (deg) | 90, 96.7, 90 | 90, 90, 90 | ||
all | outer shell | all | outer shell | |
resolution (Å) | 48.51–2.90 | 3.06–2.90 | 54.62–2.34 | 2.42–2.34 |
Rmergea | 0.116 | 0.83 | 0.152 | 0.963 |
Rpimb | 0.040 | 0.290 | 0.049 | 0.300 |
CC1/2c | 0.998 | 0.881 | 0.998 | 0.62 |
no. of total reflections | 104271 | 15039 | 225549 | 22220 |
no. of unique reflections | 11440 | 1689 | 19 709 | 1860 |
mean ((I)/sd(I)) | 13.9 | 3.3 | 13.1 | 2.9 |
completeness (%) | 100 | 100 | 100 | 100 |
multiplicity | 9.1 | 8.9 | 11.4 | 11.9 |
Rwork/Rfreed | 0.231/0.297 | 0.221/0.264 | ||
bonds (Å) | 0.003 | 0.004 | ||
angles (deg) | 0.641 | 0.916 | ||
Ramachandran outliers (%) | 0 | 0 | ||
Ramachandran favored (%) | 95.5 | 97.7 | ||
no. of residues | 426 | 428 | ||
average B factor protein (Å2) | 71.6 | 57.6 | ||
no. of waters | 4 | 53 | ||
average B factor waters (Å2) | 56.8 | 56.9 | ||
MolProbity score | 1.73 | 1.41 |
Rmerge = ∑h ∑i |Ii(h) – I̅(h)|/∑h ∑iIi(h).
Rpim = ∑h (1/N – 1)1/2 ∑i |Ii(h) – I̅(h)|/∑h ∑iIi(h),h is the given reflection, I̅(h) is the average intensity of each reflection and i is the ith measurement of reflection h.
CC1/2 is the Pearson correlation coefficient between random half-data sets.
Rwork = ∑h |Fobs(h) – Fcalc(h)|/∑hFobs(h); Rfree corresponds to the Rwork based on 5% of the data excluded from refinement.
Small Angle X-ray Scattering and Differential Scanning Calorimetry
Data of hUSP11DU samples were collected at 7.6, 3.8, and 1.9 mg mL–1 in 50 mM Tris-Cl, pH 7.4, 150 mM NaCl at beamline X33 at the DORIS-III storage ring at DESY, Germany. Buffer subtracted curves were processed using the program Primus.32 The radius of gyration, Rg, was determined using the Guinier approximation at very low scattering angles using 64 data points (72–135) from the merged buffer subtracted curves which fell within the accepted range of 0.6 < qRg < 1.3. The Dmax was determined from the distance distribution p(r) function using the program Gnom.33Ab initio model building was carried out using the program DAMMIN. The DAMAVER program was used to produce an average model and create a solvent reduced molecular envelope from 15 independent ab initio models built in DAMMIN followed by DAMFILT for filtering to obtain a representative dummy atom model.32 The hUSP11DU crystal structure with the domain swapped dimer and a monomeric model was used to generate theoretical scattering curves in CRYSOL. The hUSP11DU monomeric model was created to generate a single chain with a DU finger β-hairpin by superimposing the individual DUSP and UBL domains onto the rUSP11DU structure and replacing the coordinates of hUSP11DU residues 143–148 with the coordinates of residues 135–140 from rat with the human sequence. These models were fitted into the ab initio molecular envelope using the program Chimera.34
For differential scanning calorimetry (DSC), 2 mg mL–1 h USP11DU, hUSP15DU, and hUSP4DU were dialyzed into PBS buffer, 10 mM phosphate buffer, 2.7 mM KCl, 137 mM NaCl pH 7. Data were collected on a Microcal VP-DSC calorimeter at a scan rate of 1 °C min–1 with a low feedback mode/gain. Data were analyzed using the Origin 7.0 software (MicroCal). All DU domain samples unfolded irreversibly and visibly aggregated following thermal denaturation.
Kinetic Assays and Diubiquitin Chain Selectivity Assay
Deubiquitination assays were performed with human FL-USP11, FLΔUBL2, and CatΔUBL2 at a concentration of 75 nM enzyme and 0.1 μM to 1.5 μM ubiquitin-AMC (7-amino-4-methylcoumarin) as the fluorogenic substrate. Reactions were carried out in 150 mM NaCl, 50 mM Tris-Cl pH 7.5, 1 mM DTT, in 384-well black plates (Nunc) with 30 μL final volumes in triplicate. Plates were read with an EnVision 2104 multilabel plate reader at 25 °C using excitation wavelength 355 nm and emission wavelength 426/428 nm. Measurements were taken every minute for the first 20 min, then every 2 min for the next 30 min, and subsequently at increasing intervals of 5, 10, and 20 min. Curves containing 15 data points measured in triplicate were fitted using nonlinear regression analysis in GraphPad prism software to establish Km and kcat values.
Diubiquitin chain cleavage assays were performed with all three proteins at a concentration of 75 nM enzyme with 5 μM of the eight diubiquitin linkage types: linear, Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, and Lys63 (Viva Bioscience). Reactions were carried out in 150 mM NaCl, 50 mM Tris-Cl pH 7.5, 1 mM DTT at 23 °C in duplicate. Five microliter samples were taken at 0, 5, 10, 30, 60, 120, and 180 min with a final sample taken at 19 h. Reactions were stopped by the addition of SDS-PAGE loading buffer and analyzed on Novex Tris-Glycine 18% SDS-PAGE. Gels were stained with Coomassie blue followed by EZBlue. Gels were scanned and then analyzed with the ImageJ software where relative amounts of diubiquitin and monoubiquitin for each time point were determined. The mean diubiquitin percentage was calculated from duplicate SDS-PAGE gels and plotted using GraphPad Prism software using nonlinear regression analysis.
Results
Structures of Human and Rat USP11 N-Terminal DU Domains
To investigate the structure of USP11, we initially focused our attention on the N-terminal DU domains as we observed these domains as a common breakdown product during expression and in limited proteolysis experiments with full-length USP11. We therefore cloned human USP11 N-terminal constructs spanning residues 1–244 and 24–244 harboring the predicted DUSP and UBL domains. The first 23 residues are highly alanine rich and are predicted to be disordered using the RONN server,35 and we only obtained crystals with the latter construct. In order to potentially obtain a higher resolution structure and investigate the evolutionary conservation of USP11, we also designed an analogous N-terminal construct for the rat ortholog (residues 19–236) for which we also obtained diffraction quality crystals. The structures were solved using molecular replacement and statistics are summarized in Table 1.
The 2.9 Å structure of hUSP11DU shows that the two copies in the asymmetric unit pack in a domain swapped dimeric arrangement (Figure 1B) via an extended linker region (residues 141–152) in the crystal. The first ∼110 N-terminal residues adopt a three helix bundle stacked against a three-strand antiparallel β-sheet adopting the DUSP fold first characterized in USP15.36 A distinctive feature in the DUSP domain of hUSP11 compared to other DUSP structures is that in the N-terminal helix 1 residues 45–48, GESG, break the helix after two turns creating a short loop where Glu46 and Ser47 are solvent exposed and not engaged in crystal contacts. Loop 2 (L2) comprising residues Gly76-Asp111 in hUSP11 (Figure 1B) is tethered to the DUSP surface by interactions from residues Pro85 and Ile88 with Trp66 from α-helix 2. These residues form part of the signature PGPI sequence identified by bioinformatic analysis as being shared by DUSP domains from seven distinct USPs,36 but the second proline is substituted by Cys87 in hUSP11DU. Prior to strand S2 there is a turn spanning residues Glu108-Asp111 that contains several acidic residues with the sequence EGED. This loop forms the central feature of a cleft, which involves residues on the surface of the DUSP domain and includes part of the interface between the DUSP and the interdomain linker region (Figures 1 and 3F). In the crystal, the linkers between the DUSP and UBL domains form an antiparallel β-sheet which is interrupted at the center by Pro144 in such a way that the DUSP domain from one chain stacks against the UBL domain from the other (Figure 1B,C). Representative electron density for the linker region is shown in Figure S1A (Supporting Information). The DUSP domain is anchored to the linker region by an extensive predominantly hydrophobic interface which involves 14 residues covering 1508 Å2 in hUSP11DU (PISA server at the EBI37). The interaction is dominated by a conserved VEVY motif in the linker where the two valine residues, Val149 and Val151, are almost completely buried (Figure 1C).
Residues 154–244 adopt a β-grasp ubiquitin-like fold with a second short helical turn inserted between strands 4′ and 5′ comprising residues 218–220 (Figure 1B). The UBL domain is anchored to the linker region by Glu150 from this VEVY motif (Figure 1C) through side chain mediated hydrogen bonds with Ser173 and the backbone amine of the upstream residue His174. Residue Tyr152 from the VEVY motif positioned prior to the bridging residue to the UBL domain, Pro153, forms hydrogen bonding interactions with main chain groups from Lys103 and Leu106. The side chain of His174 forms a hydrogen bond with the main chain carbonyl of Tyr152 (Figure 1C). Interchain interactions between Ile141, Leu143, and Thr175, Leu219 are also seen. These interactions are the only contacts between the UBL domain to either the linker or the DUSP domain.
Clearly identifiable USP11 orthologues are only found in vertebrates, and USP11 is less conserved across species compared to USP4 and USP15 (Figure 2A,B). hUSP11DU and rUSP11DU share 76.1% sequence identity, and the two DUSP domains can be aligned with an RMSD of 0.7 Å and the UBL domains with an RMSD of 1.5 Å. Interestingly, in the 2.3 Å crystal structure of USP11 from rat (rUSP11DU) the linker region (residues 133–144) forms a β-hairpin capped by a type II β-turn with residues Pro136 and Gly137 at its center (highlighted in cyan in Figures 1D,E and Figure S1B, Supporting Information). This turn causes the DUSP and UBL domains to pack in a side by side tandem arrangement mediated by a small interface comprising ∼200 Å2 (Figure 1D,E). Nevertheless, in rUSP11DU, the DUSP and linker region form an equivalent interface to that of hUSP11DU (Figure 1C,E). In the rUSP11DU structure, this involves residues from the same chain due to the formation of the β-hairpin DU finger (termed in analogy to the homologue USP1523) as opposed to involving a second chain in the domain swapped arrangement of the hUSP11DU crystal structure. The majority of structural features are conserved such as the acidic loop in the DUSP domain (residues 100–103 EGDD) and hydrophobic contacts at the two domain interface involving Ile133 and Leu135 from the DU finger region and Ser167 and Leu211 in the UBL domain in rUSP11. hUSP11DU His174 is replaced by Tyr166 in the rUSP11DU structure at the interface, but the VEVY motif is conserved. However, despite the significant sequence similarities, some DU surface features are not conserved. In the rUSP11DU structure, Pro136 and Gly137 form the DU finger β-turn, whereas the equivalent hUSP11DU residues Pro144 and Asn145 are at the center of the linker in the crystal structure. The hUSP11 DUSP domain contains a three residue insertion in the N-terminal α-helix, not present in known USP11 sequences from most other species including rat (Figure 2A). In rUSP11DU, α-helix 1 has three turns, lacking this insertion. It is possible that these residues mediate protein–protein interactions specific to hUSP11. Glu43 in hUSP11DU preceding this insertion in α-helix 1 is substituted by a glycine, Gly38, in rat. The acidic residue contributes to this otherwise conserved DUSP surface cleft formed by α-helix 1, α-helix 3, and β-strand, S2 (Figures 3D,F and S2B). The surface exposed loop which connects strand S1′ and S2′ in the UBL domain is also variable in sequence and surface charge (Figure 2A) between rat and human USP11. The position of the UBL domain relative to the DUSP domain varies by up to 15 degrees between molecules, mainly mediated through a hinge point at the start of the UBL domain following a proline (Pro145 in rat or Pro153 in human), Figure 3A.
Ubiquitin (DALI Z score 11.3, PDB code 1TBE, 15% seq id.) and the related modifier ISG15 (Dali Z-score 11.7, PDB code 3PHX, 18% seq id., 1.4 Å RMSD) are identified as the closest structural neighbors to the USP11 UBL domain excluding the homologous USP4 and USP15 UBL structures using a database search with DALI.38 Despite poor sequence conservation, 15.8% and 11.8% sequence identity with the human and rat USP11 UBL domain respectively, the domains align to ubiquitin (PDB code 1UBQ(39)) with an RMSD of 1.6 Å over 70 Cα positions. The main structural difference between the USP11 UBL domain and ubiquitin involves the presence of a longer loop region between strands S3′ and S4′ comprising the sequence SEGS (Figure 1B,D). This loop region is often involved in protein–protein interactions in UBL domains.40
None of the lysine residues or surface features described in ubiquitin are well conserved in the USP11 UBL domain of the DU module. Asp220 in hUSP11 occupies a structurally equivalent position as Asp58 in ubiquitin, but other residues in the polar patch are not conserved. At the position of residues equivalent to the hydrophobic patch in ubiquitin, Ile44 is substituted by a bulky tryptophan residue, Trp200, while other residues in this hydrophobic patch region are buried by the hUSP11 C-terminus of the UBL domain. In contrast to the ubiquitin C-terminal diglycine motif, the hUSP11 UBL C-terminus adopts a turn involving the sequence DGTWP where Trp240 forms a π-stacking interaction against the side chain of Arg198 (Figure 1B).
Comparison of USP11 with the Homologues USP4 and USP15
USP4 and USP15 are overall less than 40% identical in sequence to USP11, but there is some functional overlap in the involvement of these enzymes in TGFβ signaling.41−44 Common binding partners between USP11, USP15, and USP4 are not known at present.45 The two USP11 DU structures allow us to define hallmarks of the DUSP-UBL module in USP4, USP15, and USP11 as well as delineating the characteristics of USP11. The structure of the hUSP11 DUSP domain can be superimposed onto the structure of hUSP15DU, PDB code 3T9L(23) with an RMSD of 1.2 Å over 103 Cα positions (seq id. 44%) and the UBL domains with an RMSD of 1.1 Å over 98 Cα positions (seq id. 34%). Similarly, the hUSP11 DUSP domain aligns to the structure of murine USP4DU, PDB code 3JYU (SGC) with an RMSD of 1.3 Å over 103 Cα positions (seq id. 41%) and an RMSD of 1.6 Å over 99 Cα positions for the UBL domain (seq id. 33%), respectively.
We reported a β-hairpin structure at the interface of the two domains denoted the DU finger in USP15,23 which is also observed in the USP4DU structure (PDB code 3JYU, SGC). Unexpectedly, in the rUSP11DU structure a tight turn is observed aided by Pro136 and Gly137 to preserve the β-hairpin despite a three residue deletion in the DU finger region compared to USP15 and USP4. In USP15 and USP4 the turn involves five residues and is topped by phenylalanine residues that are conserved among USP15 and USP4 orthologues23,24 (Figure 3C). A domain swapped dimeric arrangement has been observed in one of the available hUSP15DU structures (PDB code 3PV1(24)), highlighting that under certain conditions DU finger opening can occur, and a strand from another molecule can complete the antiparallel β-sheet of the β-hairpin. It is curious that in our USP11 as well as a USP15 DU structure, this opening is observed through “peeling off” of the VEVY motif to be replaced by the same motif of another molecule independent of the different lengths of the DU finger. Whether this purely represents a crystallographic artifact or has any functional significance remains to be determined.
Eight out of nine hydrophobic residues defining the DUSP domain-linker interactions including the VEVY motif are absolutely conserved in all of the USP15, USP4, and USP11 sequences (Figure 2A). The only other absolutely conserved region in the USP11, USP15, and USP4 N-terminal domains not contributing to the hydrophobic core constitutes the C-terminal DGTWP motif that loops back onto the UBL domain (Figures 1B,D and 3E). Loop 2 is one of the most variable regions among the DU family of USPs (Figures 2A, 3B, and S2A; Supporting Information) and is six residues shorter in USP11 compared to USP15 and USP4. USP11 thus lacks solvent exposed tryptophan and tyrosine residues present in USP4 and USP15.
A relatively hydrophobic crescent shaped cleft (Figure 3F) may constitute a potential protein–protein interaction site in the USP4 and USP15 DUSP domain structures.23,24 In USP4, Phe127 at the tip of the DU finger extends into a deeper hydrophobic pocket at this location in a second copy of the protein in the asymmetric unit (Figure 3F). In hUSP11 this region is also predominantly hydrophobic, but several surface exposed residues from helix 1, helix 2 and surrounding residues are not identical in this region (Figures 3D,F and S2B; Supporting Information). These include Tyr67, which is substituted by Phe38 and Phe42 in USP15 and USP4, respectively, and forms a hydrogen bond with Glu43 and Arg49 in hUSP11 (Leu20 and Met24 in USP15 and USP4 respectively) and Glu46. In USP11, the side chain of Arg49 fills the respective deep hydrophobic pocket where in USP4 the side chain of Phe127 is buried (Figures 3D and S2B; Supporting Information). In this area, there are also differences in charge whereby Glu71 (USP15 Lys42, USP4 Lys46) forms an additional hydrogen bond to the conserved surface exposed Lys68 in USP11. At the position of Gly109, USP15 and USP4 harbor glutamic acid residues.
In order to better understand the solution behavior of the DU domains, we conducted thermal unfolding studies using differential scanning calorimetry (Figure S3F, Supporting Information). USP11, USP15, and USP4 DU domains each display a melting transition with a single peak, suggesting that the dissociation between the DUSP and UBL domains either produces insufficient heat to be measured by the method or occurs simultaneously with thermal unfolding of both domains. Notably, the melting transition was significantly different between USP15 and the closely related USP4 constituting a 7 °C shift in temperature and thus was not dependent on the DUSP-UBL interface area.
The USP11 DUSP-UBL Domains and Full-Length USP11 Are Monomeric in Solution
The occurrence of the domain swapped dimeric arrangement in the human USP11DU crystal structure raised the question about the predominant form in solution. During purification USP11DU elutes on size exclusion column at a volume consistent with a monomer in agreement with SEC-MALLS experiments.24 At concentrations associated with crystallization we see a small, about 5%, fraction of dimeric hUSP11DU on gel filtration. In order to further investigate the oligomeric state of hUSP11DU in solution, we used small-angle X-ray solution scattering. USP11DU has a radius of gyration (Rg), calculated from the Guinier plot, of 27.8 Å. From a p(r) function a maximum dimension (Dmax) of 97.2 Å was estimated. Ab initio model building resulted in molecular envelopes consistent with a two domain structure of a hUSP11DU monomer, with insufficient space to accommodate a dimer. Using the hUSP11 structure, where a DU finger β-hairpin based on the rUSP11DU structure was modeled, resulted in a good fit, and the theoretical and experimental scattering curves agree (Figure S3A–E, Supporting Information). The additional volume in the molecular envelope can be explained by the hydration shell and flexible residues at the N- and C-termini that are not present in the crystal structure.
For hUSP15DU, an Rg of 26.6 Å and a Dmax of 81 Å have been reported.23 The presence of a DU finger β-hairpin in the rUSP11DU structure and the conservation of the DUSP-linker interface in the hUSP11DU structure suggest that the differences are most likely due to the relative orientation of the UBL domain, an additional four residues at the N-terminus compared to USP15, and a flexible C-terminal His-tag that all contribute to the apparent Dmax and Rg. Furthermore, we investigated the oligomerization state of full-length hUSP11 using gel filtration which showed that full-length hUSP11 is monomeric in solution (Figure S3G, Supporting Information).
Influence of the USP11 DUSP-UBL and UBL2 Domains on the Catalytic Function
As UBL domains have been shown to modulate USP activity,5,18,46,47 we were interested in whether the DUSP-UBL module or the UBL2 domain of USP11 have an effect on the catalytic activity. In order to investigate the role of USP11 ancillary domains in regulating the catalytic activity, we designed and cloned several deletion constructs of USP11 that contain the protease domain (Figure 4A). The overall yield for full-length USP11 (FL-USP11) was poor, but pure and stable protein suitable for assays was obtained (Figure 4B). Deletion constructs lacking either the DUSP domain alone or the N-terminal DUSP-UBL domains had a very low level of expression and were prone to precipitation and as such were not further utilized. However, we obtained pure protein of around 2 mg L–1 of culture by replacing the UBL2 containing insert with a short linker. A further construct suitable for assays was obtained by removal of the DUSP-UBL domain from the ΔUBL2 fusion construct (Figure 4A,B).
The activity of full-length USP11 was assayed using the fluorogenic substrate ubiquitin-AMC (Figure 4C). We observed a Km of 0.55 μM which is consistent with Km values reported ranging from 0.12–0.77 μM.1,16 Comparison of FL-USP11 to the construct lacking the catalytic domain UBL2 containing insert, FLΔUBL2, showed that these constructs display similar kinetic parameters as summarized in Figure 4C. Furthermore, the kinetic parameters for FLΔUBL2 and a construct additionally missing the N-terminal DU domains, CatΔUBL2, were comparable (Figure 4C). The Vmax and accordingly the kcat values are slightly higher in the FLΔUBL2 protein indicating that removal of the UBL2 insert may lead to a marginal increase in catalytic efficiency. However, a significant inhibitory or activating role for the UBL domains was not observed as reported for other USPs.47 Deletion of the DU module and UBL2, or the UBL2 containing insert alone, did neither significantly increase nor decrease the Km compared to the full-length enzyme. Slow conformational changes involving the active site loops are the most likely cause for the sigmoidal kinetic behavior observed with all catalytic domain constructs (Figure 4C), but further investigation is needed to confirm this. This kinetic behavior has also been observed for other USPs.1 Moreover, we investigated whether the DUSP-UBL domains are able to interact with ubiquitin and did not detect any interaction using ITC or gel filtration (Figure S4, Supporting Information). These data suggest that the catalytic activity of the USP11 protease domain is not modulated through ancillary domains using ubiquitin-AMC as model substrate.
USP11 Displays Specificity for Different Ubiquitin Chain Linkages and This Is Mediated by the Protease Domain
We subsequently investigated the effect of the removal of ancillary USP11 domains on the specificity for diubiquitin substrates of all eight known linkages occurring in the cell. On the basis of diubiquitin chain cleavage time-courses, FL-USP11 displayed little detectable activity for linear chains and highest activity toward Lys63- and Lys6-linked chains. Interestingly, FLΔUBL2 and CatΔUBL2 showed these same preferences (Figure 5). On the basis of these six independent experiments, the eight different diubiquitin linkages can broadly be split into three main groups by preference of all three proteins tested: Lys6- and Lys63-linked chains showed the highest levels of cleavage, Lys11- and Lys33-linked chains showed moderate cleavage, and Lys27-, Lys29-, Lys48-linked and linear chains demonstrated the lowest levels of cleavage. We conducted gel image analysis to further evaluate the data (Figures 5B and S5; Supporting Information). On the basis of the results for all three USP11 catalytic domain constructs investigated, more than 65% of Lys63- and Lys6-linked diubiquitin was cleaved within 3 h and more than 85% after 19 h. FL-USP11 with Lys63-linked and FLΔUBL2 with Lys6-linked chains as substrates showed complete cleavage after 19 h. Lys33- and Lys11-linked chains were cleaved to more than 35% after 3 h and more than 45% after 19 h. Linear, Lys48-, Lys29-, and Lys27-linked diubiquitin chains were cleaved to less than 30% after 3 h and less than 50% even after 19 h.
Two subtle differences were observed between the different constructs tested. Notably, Lys27-linked diubiquitin chains were cleaved to about 50% by FL-USP11 after 19 h. In the same time, FLΔUBL2 and CatΔUBL2 only cleaved about 32% of this substrate. Additionally, for linear diubiquitin virtually no cleavage was observed with FLΔUBL2, whereas FL-USP11 and CatΔUBL2 showed some residual activity (about 10% of the linear diubiquitin was cleaved after 19 h). Taken together, USP11 displays chain specificity, and comparison of FL-USP11 and the deletion mutants indicates that this preference for certain chains is mediated by the protease domain core in vitro.
Discussion
It is vital for ubiquitin specific proteases to be able to tightly regulate their catalytic activity as they occupy key positions in important signaling pathways.48 A range of variable domains are involved in these functions in a number of USPs. For example, UBL domains have been shown to regulate a USP through activation5,46 and possibly can also inhibit the catalytic activity of USPs, although the latter remains to be confirmed.18,19,47 The function of USP11 as an important modulator of DNA damage repair is beginning to emerge.9,10 Here, we undertook an analysis of the USP11 domain structure, investigated the impact of domain deletion mutants on the catalytic function (Figures 4 and 5), and solved the crystal structures of the human and rat USP11 N-terminal DUSP and UBL domains (Figure 1). The monomeric state in solution, molecular envelope, and the presence of the conserved DUSP-UBL interface suggest the formation of the DU finger β-hairpin in hUSP11DU in an analogous way to that observed in the structure of rat USP11DU. Consistent with a DU finger region in hUSP11, asparagine is a favored residue in the i+2 position of type II β-turns.49 The absence of the protease domain may favor domain swapped dimers under certain conditions and is unlikely to occur in the full length protein that behaves as a monomer. We therefore anticipate that the physiological form of USP11 is a monomer. However, we cannot rule out that conformational changes involving DU finger opening through detachment of the VEVY motif may occur under some conditions as this is observed in our hUSP11 as well as one USP15 DU structure.24 Through comparison to the homologues USP4 and USP15 (Figures 2 and 3), we have highlighted several novel features in USP11 including: (i) the absence of a pronounced hydrophobic DUSP pocket previously predicted to constitute a protein binding site due to sequence variations in the N-terminal helix and surrounding residues. Differences in this region were even observed between the structures of the closely related species human and rat due to the presence of an additional three residues in the N-terminal helix of human USP11; (ii) significant surface loop variations, especially in the DUSP domain including regions L1 and L2. Although most insertions/deletions occur in the DUSP domain, the adjacent UBL domain is overall even less conserved; (iii) a shortened DU finger region (L4) that lacks a phenylalanine at the tip that may be involved protein–protein interactions in USP4 and USP15. In USP11, residues at the tip of the DU finger are also not conserved across species. These variations are consistent with functional differences, since many of the binding partners for USP4 have also been identified for USP15, whereas binding partners of USP11 are more unique.45
Two common structural signature motifs of the DU module found in USP11, USP4, and USP15 can be defined. First, 14 conserved residues including a VEVY motif locate to the interface formed between the linker region and the DUSP domain, highlighting the importance of this interface as a key feature of the DU domain module. USP DU domains are predominantly monomeric in solution and adopt a tandem arrangement of the DUSP and UBL domains including a DU finger β-hairpin. The inherent moderate flexibility between the two domains may indicate that they can have discrete functions as well as acting as one functional unit. Second, the C-terminal part of the UBL domains is characterized by a distinctive loop region not present in other UBL domains including the conserved DGTWP sequence in all members of the DU family.
In total, 7 human USPs harbor DUSP domains36 and 16 USPs harbor UBL domains, whereby UBL domains nested within the catalytic core are present in eight USPs.17 UBL domains found in USPs are relatively poorly conserved and a common function is not known. The DUSP domains, although exclusively found in ubiquitin specific proteases, also display a great diversity. and the only common stretch of sequence identified previously, the PGPI motif,36 does not seem to be important other than for the fold of the DUSP domain.
We show that the USP11 UBL domain displays distinct surface characteristics compared to ubiquitin, but ubiquitin is still a relatively close structural neighbor, despite poor sequence conservation. Since USPs often contain additional ubiquitin binding domains,3 we also investigated ubiquitin binding to the N-terminal domains. The experiments revealed that the USP11 DU domains do not bind ubiquitin with detectable affinities (Figure S4, Supporting Information) or affect the catalytic efficiency of the enzyme using ubiquitin-AMC as substrate (Figure 4). In addition to N- or C-terminal additional domains, the catalytic core domain of USP family members often contains insertions that encode variable domains.2 A common insertion point lies close to the distal ubiquitin binding site and was proposed to include an autoinhibitory UBL domain in hUSP4.18,19 We did not observe an autoregulatory role for the equivalent region in hUSP11 as a construct missing this insert displayed broadly similar kinetic parameters for cleavage of the model substrate Ub-AMC. This shows that in USP11 these domains are not directly involved in regulating the enzymatic activity of the enzyme and highlights the diversity of regulatory mechanisms in USPs. It is still possible that these additional domains of hUSP11 may have a regulatory role through the interaction with other proteins. Such a regulatory function through accessory proteins has been described for some USPs such as USP7, USP1, USP12, and USP46.1,50,51 The USP11 DU domains and internal UBL2 may also be involved in trafficking or recruiting specific substrates to the catalytic domain.
We show that USP11 preferably cleaves Lys63-, Lys6-, Lys33-, and Lys11-linked ubiquitin chains over Lys27-, Lys29-, Lys48-linked and linear chains. Interestingly, all deletion constructs employed displayed a marked preference for Lys63- and Lys6-linked chains in vitro. This is consistent with the DU domains not forming significant interactions with ubiquitin during the catalytic cycle and locates this chain preference to the core protease domain. The ubiquitin chains preferentially cleaved by USP11 adopt quite different conformations. Lys63-linked chains tend to adopt extended conformations,52,53 whereas Lys6-linked chains are more compact.54,55 Both, Lys63-linked and linear chains generally adopt relatively open conformations. A high degree of flexibility and the linkage surrounding residues, e.g., the relatively bulky methionine in the linear chain, are likely to account for the differences observed. Interestingly, Lys63- and Lys6-linked ubiquitin chains have been associated with pathways that USP11 has been implicated in,7,9 namely, DNA damage repair and inflammation,56 but the functional significance of this in vivo remains to be determined. USP11’s preferential cleavage of ubiquitin chains is not comparable to the specificity of other deubiquitinating enzymes such as some OTU proteases57 in that we observed cleavage to some extent with all chains except linear diubiquitin that displayed little cleavage even upon incubation overnight. However, all USP11 constructs consistently showed less activity toward Lys27-, Lys29-, and Lys48-linked and linear chains and as such a clear preference for some chains over others. Taken together, these data advance our understanding of USP11 regulation and function in DNA damage repair pathways and viral infection.
Acknowledgments
This work was carried out with the support of the ESRF and DESY, and the authors thank beamline staff of beamlines ID23-2, ID29 and X33 for support during data collection. We thank Arie Geerlof (EMBL) for kindly providing the pRSF-13 vector. We thank Hui Lee Tan and Sonal Bakrania for contributions to early experiments and Simon Caulton for helpful suggestions and critically reading the manuscript.
Glossary
Abbreviations
- AMC
7-amino-4-methylcoumarin
- DSC
differential scanning calorimetry
- DU
DUSP-UBL
- DUSP
domain present in ubiquitin-specific proteases
- UBL
ubiquitin-like
- USP
ubiquitin specific protease
Supporting Information Available
Figures S1 (electron densities of the USP11DU linker and DU finger region), S2 (differences in the DUSP domain of USP11, USP4, and USP15), S3 (solution studies of USP11DU and FL-USP11), S4 (hUSP11DU does not detectably associate with ubiquitin in solution), and S5 (densitometric analysis of gels probing ubiquitin chain selectivity with the overnight time point included). This material is available free of charge via the Internet at http://pubs.acs.org.
Author Contributions
# S.H. and H.E.G. contributed equally to the work.
The authors declare no competing financial interest.
This work was supported by the Biotechnology and Biological Sciences Research Council through Grant BB/H012656/1 and a studentship to H.E.G., the Royal Society, and the University of Nottingham. Additional support was from the doctoral school “DK Molecular Enzymology” funded by the Austrian Science Fund (FWF) W901-B12.
Supplementary Material
References
- Faesen A. C.; Luna-Vargas M. P.; Geurink P. P.; Clerici M.; Merkx R.; van Dijk W. J.; Hameed D. S.; El Oualid F.; Ovaa H.; Sixma T. K. (2011) The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types. Chem. Biol. 18, 1550–1561. [DOI] [PubMed] [Google Scholar]
- Ye Y.; Scheel H.; Hofmann K.; Komander D. (2009) Dissection of USP catalytic domains reveals five common insertion points. Mol. Biosyst. 5, 1797–1808. [DOI] [PubMed] [Google Scholar]
- Reyes-Turcu F. E.; Ventii K. H.; Wilkinson K. D. (2009) Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363–397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ventii K. H.; Wilkinson K. D. (2008) Protein partners of deubiquitinating enzymes. Biochem. J. 414, 161–175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fernandez-Montalvan A.; Bouwmeester T.; Joberty G.; Mader R.; Mahnke M.; Pierrat B.; Schlaeppi J. M.; Worpenberg S.; Gerhartz B. (2007) Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization. FEBS J. 274, 4256–4270. [DOI] [PubMed] [Google Scholar]
- Sheng Y.; Saridakis V.; Sarkari F.; Duan S.; Wu T.; Arrowsmith C. H.; Frappier L. (2006) Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat. Struct. Mol. Biol. 13, 285–291. [DOI] [PubMed] [Google Scholar]
- Yamaguchi T.; Kimura J.; Miki Y.; Yoshida K. (2007) The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha). J. Biol. Chem. 282, 33943–33948. [DOI] [PubMed] [Google Scholar]
- Ideguchi H.; Ueda A.; Tanaka M.; Yang J.; Tsuji T.; Ohno S.; Hagiwara E.; Aoki A.; Ishigatsubo Y. (2002) Structural and functional characterization of the USP11 deubiquitinating enzyme, which interacts with the RanGTP-associated protein RanBPM. Biochem. J. 367, 87–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schoenfeld A. R.; Apgar S.; Dolios G.; Wang R.; Aaronson S. A. (2004) BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol. Cell. Biol. 24, 7444–7455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiltshire T. D.; Lovejoy C. A.; Wang T.; Xia F.; O’Connor M. J.; Cortez D. (2010) Sensitivity to poly(ADP-ribose) polymerase (PARP) inhibition identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of DNA double-strand break repair. J. Biol. Chem. 285, 14565–14571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maertens G. N.; El Messaoudi-Aubert S.; Elderkin S.; Hiom K.; Peters G. (2010) Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. EMBO J. 29, 2553–2565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liao T. L.; Wu C. Y.; Su W. C.; Jeng K. S.; Lai M. M. (2010) Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J. 29, 3879–3890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin C. H.; Chang H. S.; Yu W. C. (2008) USP11 stabilizes HPV-16E7 and further modulates the E7 biological activity. J. Biol. Chem. 283, 15681–15688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pedersen N.; Mortensen S.; Sorensen S. B.; Pedersen M. W.; Rieneck K.; Bovin L. F.; Poulsen H. S. (2003) Transcriptional gene expression profiling of small cell lung cancer cells. Cancer Res. 63, 1943–1953. [PubMed] [Google Scholar]
- Bayraktar S.; Gutierrez Barrera A. M.; Liu D.; Pusztai L.; Litton J.; Valero V.; Hunt K.; Hortobagyi G. N.; Wu Y.; Symmans F.; Arun B. (2013) USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancer. Cancer J. 19, 10–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burkhart R. A.; Peng Y.; Norris Z. A.; Tholey R.; Talbott V. A.; Liang Q.; Ai Y.; Miller K.; Lal S.; Cozzitorto J. A.; Witkiewicz A. K.; Yeo C. J.; Gehrmann M.; Napper A.; Winter J. M.; Sawicki J. A.; Zhuang Z.; Brody J. R. (2013) Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survival. Mol. Cancer Res. 11, 901–911. [DOI] [PubMed] [Google Scholar]
- Zhu X.; Menard R.; Sulea T. (2007) High incidence of ubiquitin-like domains in human ubiquitin-specific proteases. Proteins 69, 1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luna-Vargas M. P.; Faesen A. C.; van Dijk W. J.; Rape M.; Fish A.; Sixma T. K. (2011) Ubiquitin-specific protease 4 is inhibited by its ubiquitin-like domain. EMBO Rep. 12, 365–372. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- Luna-Vargas M. P.; Faesen A. C.; Van Dijk W. J.; Rape M.; Fish A.; Sixma T. K. (2014) Retraction:’Ubiquitin-specific protease 4 is inhibited by its ubiquitin-like domain. EMBO Rep. 15, 121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Song E. J.; Werner S. L.; Neubauer J.; Stegmeier F.; Aspden J.; Rio D.; Harper J. W.; Elledge S. J.; Kirschner M. W.; Rape M. (2010) The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome. Genes Dev. 24, 1434–1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao B.; Velasco K.; Sompallae R.; Pfirrmann T.; Masucci M. G.; Lindsten K. (2012) The ubiquitin specific protease-4 (USP4) interacts with the S9/Rpn6 subunit of the proteasome. Biochem. Biophys. Res. Commun. 427, 490–496. [DOI] [PubMed] [Google Scholar]
- Hayes S. D.; Liu H.; MacDonald E.; Sanderson C. M.; Coulson J. M.; Clague M. J.; Urbe S. (2012) Direct and indirect control of mitogen-activated protein kinase pathway-associated components, BRAP/IMP E3 ubiquitin ligase and CRAF/RAF1 kinase, by the deubiquitylating enzyme USP15. J. Biol. Chem. 287, 43007–43018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harper S.; Besong T. M.; Emsley J.; Scott D. J.; Dreveny I. (2011) Structure of the USP15 N-terminal domains: a beta-hairpin mediates close association between the DUSP and UBL domains. Biochemistry 50, 7995–8004. [DOI] [PubMed] [Google Scholar]
- Elliott P. R.; Liu H.; Pastok M. W.; Grossmann G. J.; Rigden D. J.; Clague M. J.; Urbe S.; Barsukov I. L. (2011) Structural variability of the ubiquitin specific protease DUSP-UBL double domains. FEBS Lett. 585, 3385–3390. [DOI] [PubMed] [Google Scholar]
- Hu M.; Li P.; Song L.; Jeffrey P. D.; Chenova T. A.; Wilkinson K. D.; Cohen R. E.; Shi Y. (2005) Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J. 24, 3747–3756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gorrec F. (2009) The MORPHEUS protein crystallization screen. J. Appl. Crystallogr. 42, 1035–1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collaborative Computational Project, N. (1994) The CCP4 suite: programs for protein crystallography, Acta Crystallogr. D Biol. Crystallogr. 50, 760–763. [DOI] [PubMed] [Google Scholar]
- McCoy A. J.; Grosse-Kunstleve R. W.; Adams P. D.; Winn M. D.; Storoni L. C.; Read R. J. (2007) Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adams P. D.; Afonine P. V.; Bunkoczi G.; Chen V. B.; Davis I. W.; Echols N.; Headd J. J.; Hung L. W.; Kapral G. J.; Grosse-Kunstleve R. W.; McCoy A. J.; Moriarty N. W.; Oeffner R.; Read R. J.; Richardson D. C.; Richardson J. S.; Terwilliger T. C.; Zwart P. H. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Painter J.; Merritt E. A. (2006) Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D Biol. Crystallogr. 62, 439–450. [DOI] [PubMed] [Google Scholar]
- Kabsch W. (2010) Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Konarev P. V.; Petoukhov M. V.; Volkov V. V.; Svergun D. I. (2006) ATSAS 2.1, a program package for small-angle scattering data analysis. J. Appl. Crystallogr. 39, 277–286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Svergun D. I. (1992) Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 25, 495–503. [Google Scholar]
- Pettersen E. F.; Goddard T. D.; Huang C. C.; Couch G. S.; Greenblatt D. M.; Meng E. C.; Ferrin T. E. (2004) UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612. [DOI] [PubMed] [Google Scholar]
- Yang Z. R.; Thomson R.; McNeil P.; Esnouf R. M. (2005) RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 21, 3369–3376. [DOI] [PubMed] [Google Scholar]
- de Jong R. N.; Ab E.; Diercks T.; Truffault V.; Daniels M.; Kaptein R.; Folkers G. E. (2006) Solution structure of the human ubiquitin-specific protease 15 DUSP domain. J. Biol. Chem. 281, 5026–5031. [DOI] [PubMed] [Google Scholar]
- Krissinel E.; Henrick K. (2007) Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797. [DOI] [PubMed] [Google Scholar]
- Holm L.; Sander C. (1995) Dali: a network tool for protein structure comparison. Trends Biochem. Sci. 20, 478–480. [DOI] [PubMed] [Google Scholar]
- Vijay-Kumar S.; Bugg C. E.; Cook W. J. (1987) Structure of ubiquitin refined at 1.8 Å resolution. J. Mol. Biol. 194, 531–544. [DOI] [PubMed] [Google Scholar]
- Dreveny I.; Kondo H.; Uchiyama K.; Shaw A.; Zhang X.; Freemont P. S. (2004) Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47. EMBO J. 23, 1030–1039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aggarwal K.; Massague J. (2012) Ubiquitin removal in the TGF-beta pathway. Nat. Cell Biol. 14, 656–657. [DOI] [PubMed] [Google Scholar]
- Al-Salihi M. A.; Herhaus L.; Macartney T.; Sapkota G. P. (2012) USP11 augments TGFbeta signalling by deubiquitylating ALK5. Open Biol. 2, 120063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eichhorn P. J.; Rodon L.; Gonzalez-Junca A.; Dirac A.; Gili M.; Martinez-Saez E.; Aura C.; Barba I.; Peg V.; Prat A.; Cuartas I.; Jimenez J.; Garcia-Dorado D.; Sahuquillo J.; Bernards R.; Baselga J.; Seoane J. (2012) USP15 stabilizes TGF-beta receptor I and promotes oncogenesis through the activation of TGF-beta signaling in glioblastoma. Nat. Med. 18, 429–435. [DOI] [PubMed] [Google Scholar]
- Zhang L.; Zhou F.; Drabsch Y.; Gao R.; Snaar-Jagalska B. E.; Mickanin C.; Huang H.; Sheppard K. A.; Porter J. A.; Lu C. X.; ten Dijke P. (2012) USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-beta type I receptor. Nat. Cell Biol. 14, 717–726. [DOI] [PubMed] [Google Scholar]
- Sowa M. E.; Bennett E. J.; Gygi S. P.; Harper J. W. (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Faesen A. C.; Dirac A. M.; Shanmugham A.; Ovaa H.; Perrakis A.; Sixma T. K. (2011) Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. Mol. Cell 44, 147–159. [DOI] [PubMed] [Google Scholar]
- Faesen A. C.; Luna-Vargas M. P.; Sixma T. K. (2012) The role of UBL domains in ubiquitin-specific proteases. Biochem. Soc. Trans. 40, 539–545. [DOI] [PubMed] [Google Scholar]
- Kim J. H.; Park K. C.; Chung S. S.; Bang O.; Chung C. H. (2003) Deubiquitinating enzymes as cellular regulators. J. Biochem 134, 9–18. [DOI] [PubMed] [Google Scholar]
- Hutchinson E. G.; Thornton J. M. (1994) A revised set of potentials for beta-turn formation in proteins. Protein Sci. 3, 2207–2216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van der Knaap J. A.; Kumar B. R.; Moshkin Y. M.; Langenberg K.; Krijgsveld J.; Heck A. J.; Karch F.; Verrijzer C. P. (2005) GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Mol. Cell 17, 695–707. [DOI] [PubMed] [Google Scholar]
- Cohn M. A.; Kee Y.; Haas W.; Gygi S. P.; D’Andrea A. D. (2009) UAF1 is a subunit of multiple deubiquitinating enzyme complexes. J. Biol. Chem. 284, 5343–5351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Varadan R.; Assfalg M.; Haririnia A.; Raasi S.; Pickart C.; Fushman D. (2004) Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J. Biol. Chem. 279, 7055–7063. [DOI] [PubMed] [Google Scholar]
- Komander D.; Reyes-Turcu F.; Licchesi J. D.; Odenwaelder P.; Wilkinson K. D.; Barford D. (2009) Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep 10, 466–473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Virdee S.; Ye Y.; Nguyen D. P.; Komander D.; Chin J. W. (2010) Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase. Nat. Chem. Biol. 6, 750–757. [DOI] [PubMed] [Google Scholar]
- Fushman D.; Walker O. (2010) Exploring the linkage dependence of polyubiquitin conformations using molecular modeling. J. Mol. Biol. 395, 803–814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen Z. J.; Sun L. J. (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 33, 275–286. [DOI] [PubMed] [Google Scholar]
- Mevissen T. E.; Hospenthal M. K.; Geurink P. P.; Elliott P. R.; Akutsu M.; Arnaudo N.; Ekkebus R.; Kulathu Y.; Wauer T.; El Oualid F.; Freund S. M.; Ovaa H.; Komander D. (2013) OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell 154, 169–184. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.